The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Immunosuppression

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Immunosuppression

 

Psychiatry related information on Immunosuppression

 

High impact information on Immunosuppression

 

Chemical compound and disease context of Immunosuppression

 

Biological context of Immunosuppression

 

Anatomical context of Immunosuppression

 

Associations of Immunosuppression with chemical compounds

 

Gene context of Immunosuppression

 

Analytical, diagnostic and therapeutic context of Immunosuppression

References

  1. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. Scherrer, U., Vissing, S.F., Morgan, B.J., Rollins, J.A., Tindall, R.S., Ring, S., Hanson, P., Mohanty, P.K., Victor, R.G. N. Engl. J. Med. (1990) [Pubmed]
  2. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Frank, D.A., Mahajan, S., Ritz, J. Nat. Med. (1999) [Pubmed]
  3. Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2. Agrawal, B., Krantz, M.J., Reddish, M.A., Longenecker, B.M. Nat. Med. (1998) [Pubmed]
  4. Different H-2 subregions influence immunization against retrovirus and immunosuppression. Morrison, R.P., Earl, P.L., Nishio, J., Lodmell, D.L., Moss, B., Chesebro, B. Nature (1987) [Pubmed]
  5. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Benhamou, Y., Bochet, M., Di Martino, V., Charlotte, F., Azria, F., Coutellier, A., Vidaud, M., Bricaire, F., Opolon, P., Katlama, C., Poynard, T. Hepatology (1999) [Pubmed]
  6. Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy. Hecht, M., Lin, L., Kushida, C.A., Umetsu, D.T., Taheri, S., Einen, M., Mignot, E. Sleep. (2003) [Pubmed]
  7. Current thinking on chronic renal allograft rejection: issues, concerns, and recommendations from a 1997 roundtable discussion. Monaco, A.P., Burke, J.F., Ferguson, R.M., Halloran, P.F., Kahan, B.D., Light, J.A., Matas, A.J., Solez, K. Am. J. Kidney Dis. (1999) [Pubmed]
  8. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Sigal, N.H., Dumont, F.J. Annu. Rev. Immunol. (1992) [Pubmed]
  9. The current outbreak of Kaposi's sarcoma and opportunistic infections. Haverkos, H.W., Curran, J.W. CA: a cancer journal for clinicians. (1982) [Pubmed]
  10. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. Jones, J.W., Gruber, S.A., Barker, J.H., Breidenbach, W.C. N. Engl. J. Med. (2000) [Pubmed]
  11. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. Beniaminovitz, A., Itescu, S., Lietz, K., Donovan, M., Burke, E.M., Groff, B.D., Edwards, N., Mancini, D.M. N. Engl. J. Med. (2000) [Pubmed]
  12. Induction of acetylcholine receptor-specific suppression. An in vitro model of antigen-specific immunosuppression in myasthenia gravis. Bogen, S., Mozes, E., Fuchs, S. J. Exp. Med. (1984) [Pubmed]
  13. CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice. Foell, J., Strahotin, S., O'Neil, S.P., McCausland, M.M., Suwyn, C., Haber, M., Chander, P.N., Bapat, A.S., Yan, X.J., Chiorazzi, N., Hoffmann, M.K., Mittler, R.S. J. Clin. Invest. (2003) [Pubmed]
  14. Influence of methimazole on murine thyroiditis. Evidence for immunosuppression in vivo. Davies, T.F., Weiss, I., Gerber, M.A. J. Clin. Invest. (1984) [Pubmed]
  15. Prostaglandin E1 inhibits effector T cell induction and tissue damage in experimental murine interstitial nephritis. Kelly, C.J., Zurier, R.B., Krakauer, K.A., Blanchard, N., Neilson, E.G. J. Clin. Invest. (1987) [Pubmed]
  16. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine. Murahata, R.I., Mitchell, M.S. J. Natl. Cancer Inst. (1982) [Pubmed]
  17. Use of steroid creams as a possible cause of immunosuppression in homosexuals. Neumann, H.H. N. Engl. J. Med. (1982) [Pubmed]
  18. Measles virus nucleocapsid protein binds to FcgammaRII and inhibits human B cell antibody production. Ravanel, K., Castelle, C., Defrance, T., Wild, T.F., Charron, D., Lotteau, V., Rabourdin-Combe, C. J. Exp. Med. (1997) [Pubmed]
  19. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. Roselaar, S.E., Schonfeld, G., Daugherty, A. J. Clin. Invest. (1995) [Pubmed]
  20. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Locasciulli, A., Arcese, W., Locatelli, F., Di Bona, E., Bacigalupo, A. Lancet (2001) [Pubmed]
  21. Immunological consequences of HIV infection: advantage of being low responder casts doubts on vaccine development. Martínez-A, C., Marcos, M.A., de la Hera, A., Marquez, C., Alonso, J.M., Toribio, M.L., Coutinho, A. Lancet (1988) [Pubmed]
  22. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group. Vincenti, F., Kirkman, R., Light, S., Bumgardner, G., Pescovitz, M., Halloran, P., Neylan, J., Wilkinson, A., Ekberg, H., Gaston, R., Backman, L., Burdick, J. N. Engl. J. Med. (1998) [Pubmed]
  23. Inhibition of antigen-induced lymphocyte proliferation by Tat protein from HIV-1. Viscidi, R.P., Mayur, K., Lederman, H.M., Frankel, A.D. Science (1989) [Pubmed]
  24. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Scheinman, R.I., Cogswell, P.C., Lofquist, A.K., Baldwin, A.S. Science (1995) [Pubmed]
  25. Islet allograft survival after a single course of treatment of recipient with antibody to L3T4. Shizuru, J.A., Gregory, A.K., Chao, C.T., Fathman, C.G. Science (1987) [Pubmed]
  26. Mechanism of measles virus-induced suppression of inflammatory immune responses. Marie, J.C., Kehren, J., Trescol-Biémont, M.C., Evlashev, A., Valentin, H., Walzer, T., Tedone, R., Loveland, B., Nicolas, J.F., Rabourdin-Combe, C., Horvat, B. Immunity (2001) [Pubmed]
  27. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. Burke, J.F., Pirsch, J.D., Ramos, E.L., Salomon, D.R., Stablein, D.M., Van Buren, D.H., West, J.C. N. Engl. J. Med. (1994) [Pubmed]
  28. Cyclosporin immunosuppression as the possible cause of AIDS. Sell, K.W., Folks, T., Kwon-Chung, K.J., Coligan, J., Maloy, W.L. N. Engl. J. Med. (1983) [Pubmed]
  29. Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson's disease. Freed, C.R., Breeze, R.E., Rosenberg, N.L., Schneck, S.A., Kriek, E., Qi, J.X., Lone, T., Zhang, Y.B., Snyder, J.A., Wells, T.H. N. Engl. J. Med. (1992) [Pubmed]
  30. Nuclear factor of activated T cells contains Fos and Jun. Jain, J., McCaffrey, P.G., Valge-Archer, V.E., Rao, A. Nature (1992) [Pubmed]
  31. Distinct regulatory roles of lymphocyte costimulatory pathways on T helper type-2 mediated autoimmune disease. Biancone, L., Andres, G., Ahn, H., Lim, A., Dai, C., Noelle, R., Yagita, H., De Martino, C., Stamenkovic, I. J. Exp. Med. (1996) [Pubmed]
  32. B7 but not intercellular adhesion molecule-1 costimulation prevents the induction of human alloantigen-specific tolerance. Boussiotis, V.A., Freeman, G.J., Gray, G., Gribben, J., Nadler, L.M. J. Exp. Med. (1993) [Pubmed]
  33. Potential role for interleukin-10 in the immunosuppression associated with kala azar. Holaday, B.J., Pompeu, M.M., Jeronimo, S., Texeira, M.J., Sousa, A.d.e. .A., Vasconcelos, A.W., Pearson, R.D., Abrams, J.S., Locksley, R.M. J. Clin. Invest. (1993) [Pubmed]
  34. Treg-mediated immunosuppression involves activation of the Notch-HES1 axis by membrane-bound TGF-beta. Ostroukhova, M., Qi, Z., Oriss, T.B., Dixon-McCarthy, B., Ray, P., Ray, A. J. Clin. Invest. (2006) [Pubmed]
  35. The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression. Reily, M.M., Pantoja, C., Hu, X., Chinenov, Y., Rogatsky, I. EMBO J. (2006) [Pubmed]
  36. Cyclophilins: a new family of proteins involved in intracellular folding. Stamnes, M.A., Rutherford, S.L., Zuker, C.S. Trends Cell Biol. (1992) [Pubmed]
  37. Immunohistological observations in rat kidney allografts after local steroid administration. Ruers, T.J., Buurman, W.A., van Boxtel, C.J., van der Linden, C.J., Kootstra, G. J. Exp. Med. (1987) [Pubmed]
  38. Induction of immune unresponsiveness to concordant islet xenografts by intrahepatic preimmunization and transient immunosuppression. Goss, J.A., Finke, E.H., Flye, M.W., Lacy, P.E. J. Clin. Invest. (1994) [Pubmed]
  39. Randomised controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Ratcliffe, P.J., Dudley, C.R., Higgins, R.M., Firth, J.D., Smith, B., Morris, P.J. Lancet (1996) [Pubmed]
 
WikiGenes - Universities